|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease显示文摘 | Checler F | 1995 | J Neurochem1995，65，4： | 1 |
| 2 | Processing of the beta-amyloid precursor protein and its regu- lation in Alzheimer's disease 显示文摘 | Checler F | 1995 | J Neurochem1995，65，4： | 1 |
| 3 | Amyloid precursor protein,presenilins,and alpha-Synuclein:molecular pathogenesis and pharmacological applications in Alzheimer′s disease显示文摘 | Suh YH Checler F | | 0，，03： | 1 |
| 4 | P53 in neurodegenerative diseases and brain cancers 显示文摘 | CHECLER F COSTA C A D | 2014 | Pharmacol Ther2014，142，1： | 1 |
| 5 | Amyloid precursor protein,presenilins,and -synuclein:molecular pathogenesis and pharmacological applications in Alzheimer's disease显示文摘 | Suh YH Checler F | | 0，，03： | 1 |
| 6 | Processing of the beta-amyloid precursor protein and its regulation in Alzheimer disease 显示文摘 | Checler F | 1995 | J Neurechem1995，65，4： | 1 |
| 7 | Alzheimer's disease: The amyloid cascade hypothesis-20 years on显示文摘 | Checler F Turner T | 2012 | Neurochem2012，120，1： | 1 |
| 8 | BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress andβ-amyloid production in Alzheimer’s disease显示文摘 | Chami L Checler F | 2012 | Mol Neurodegener2012，7，1： | 1 |
| 9 | Alzheimer’s and prion diseases: distinctpathologies, common proteolytic denominators显示文摘 | Checler F Vincent B | 2002 | Trends Neurosci2002，25，61： | 1 |
| 10 | p53 in neurodegenerative diseases and brain cancers显示文摘 | Checler F Alves da Costa C | 2014 | Pharmacol Ther2014，142，1： | 1 |
| 11 | Combined pharmacological, mutational and cell biology approaches indicate that p53-dependent caspase 3 activation triggered by cellular prion is dependent on its endocytosis显示文摘 | Sunyach C Checler F | 2005 | J Neurochem2005，92，6： | 1 |
| 12 | Jurkat T cells express a functional neutral endopeptidase activity (CALLA) involved in T cell activation显示文摘 | Mari B Checler F Ponzio G | 1992 | EMBO J1992，11，11： | 1 |
| 13 | Amyloid precursor protein, presenilins, and α-Synuclein:molecular pathogenesis and pharmacological applications in Alzheimer's disease显示文摘 | Suh YH Checler F | 2002 | Pharmacol Rev2002，54，3： | 1 |
| 14 | Apoptosis in Parkinson/s disease: is p53 the missing link between genetic and sporadic Parkinsonism? 显示文摘 | Alves da Costa C Checler F | 2011 | Cell Siqnal2011，23，96： | 1 |
| 15 | APP epsilon,the esepsilon- secretase-derived N-terminal product of the beat-amyloid precursor protein, behaves as a type I protein and undergoes alpha-, beta-, and gamma-secretase cleavages显示文摘 | Lefranc-Jullien S Sunyach C Checler F | 2006 | J Neurochem2006，97，： | 1 |
| 16 | P53 is regulated by and regulates members of the gamma-secretase com- plex 显示文摘 | Checler F Dunys J Alves da Costa C | 2010 | Neurodegener Dis2010，1，7： | 1 |
| 17 | Apoptosis in Parkinson's disease:is p53 the missing link between genetic and sporadic Parkinsonism显示文摘 | Alves da Costa C Checler F | | 0，，06： | 1 |
| 18 | Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease 显示文摘 | Checler F | 1995 | J Neurochem1995，65，4： | 1 |
| 19 | Alzheimer's and prion diseases:distinct pathologies,common proteolytic denominators显示文摘 | Checler F Vincent B | 2002 | Trends Neurosci2002，25，： | 1 |
| 20 | Wild-type but not Parkinson's disease-related ala-53 right-arrow thr mutant alpha-syn protects neuronal cells from apoptotic stimuli 显示文摘 | da Costa CA Ancolio K Checler F | 2000 | J Biol Chem2000，275，24： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员